The FDA approves Apotex Corp.’s plan to introduce generic Ozempic, a semaglutide injection that one study suggests could someday cost as little as $3 a month. The Spokesman-Review: Generic Ozempic could cost less than $3 a month, study shows Generic versions of Novo Nordisk A/S’s hit shots Ozempic and Wegovy could be sold for under $3 a month, a new study showed, underscoring their potential to unlock global access to powerful weight-loss ... Detroit News: Generic Ozempic could cost this little a month, study shows WFXG: Apotex Receives First U.S.

Understanding the Context

FDA Tentative Approval for a Generic Version of Ozempic® (Semaglutide Injection) in Partnership with Orbicular Apotex Receives First U.S. FDA Tentative Approval for a Generic Version of Ozempic® (Semaglutide Injection) in Partnership with Orbicular The Canadian Press on MSN: These patients without drug coverage are eagerly awaiting generic Ozempic in Canada These patients without drug coverage are eagerly awaiting generic Ozempic in Canada Mint: Generic medicine makers prepare to launch affordable options after Novo's patent for Ozempic, Wegovy expires Generic medicine makers prepare to launch affordable options after Novo's patent for Ozempic, Wegovy expires